Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
06 Nov 2025 |
On P&L |
The Company releases the press release related to the first nine months of 2025 financial results
|
Download |
|
06 Nov 2025 |
On P&L |
The Company releases the first nine months of 2025 financial results presentation
|
Download |
|
21 Oct 2025 |
On business and financial situation |
The Company releases the press release in relation to the announcement of the collaboration with Roche for the manufacture of a new medicine in development
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
15 Feb 2022 |
On business and financial situation |
ROVI has announced that the European Commission has authorised the marketing of Okedi® for the treatment of schizophrenia in adults for whom tolerability and effectiveness has been established with oral risperidone.
|
Download |
|
14 Feb 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 7 February 2022 and 11 February 2022
|
Download |
|
07 Feb 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 31 January 2022 and 4 February 2022
|
Download |
|
31 Jan 2022 |
Share buy-back , stabilisation and treasury stock programme |
Share Buyback Program: transactions conducted between 24 January 2022 and 28 January 2022
|
Download |
|
24 Jan 2022 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 17 January 2022 and 21 January 2022
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the presentation related to the full year 2018 results
|
Download |
|
26 Feb 2019 |
Información sobre resultados |
ROVI releases the press release related to the full year 2018 results
|
Download |
|
15 Feb 2019 |
Others on business performance and financial information |
ROVI acquires rights to Dexchlorpheniramine Maleate in the Spanish and French markets
|
Download |
|
09 Jan 2019 |
Others on business performance and financial information |
ROVI informs about the adquisition of Falithrom® for the German market
|
Download |
|
08 Jan 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the fourth quarter of 2018
|
Download |
Pages
